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Abstract
Background: Recommendations on preventive lipid screening among children and adolescents remain
controversial. The aim of the study was to assess age and puberty-related changes in serum lipids, including total
cholesterol (TC), and high-density (HDL-C) and non-high-density lipoprotein cholesterol (Non-HDL-C).
Methods: Using cross-sectional data from the National Health Interview and Examination Survey for Children and
Adolescents in Germany (KiGGS 2003–2006; N = 13,676; 1–17 years), changes in distributions of serum lipids were
visualized according to sex, age and maturation. Youth aged 10–17 years were classified as prepubescent, early/
mid-puberty, and mature/advanced puberty. Multiple linear regressions were used to quantify the impact of
pubertal stage on serum lipid levels, adjusted for potential confounding factors.
Results: Among children 1–9 years mean serum lipid measures increased with age, with higher mean TC and Non-
HDL-C among girls than boys. Among children 10–17 years, advanced pubertal stage was independently related to
lower lipid measures. Adjusted mean TC, HDL-C and Non-HDL-C was 19.4, 5.9 and 13.6 mg/dL lower among
mature/advanced puberty compared to prepubescent boys and 11.0, 4.0 and 7.0 mg/dL lower in mature/advanced
puberty compared to prepubescent girls.
Conclusions: Lipid concentrations undergo considerable and sex-specific changes during physical growth and
sexual maturation and significantly differ between pubertal stages. Screening recommendations need to consider
the fluctuations of serum lipids during growth and sexual maturation.
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Background
There is strong evidence that cardiovascular disease has
its roots in childhood and that early lipoprotein abnormal-
ities play a crucial role in the pathogenic process [1–3].
Recommendations on preventive lipid screening among
children and adolescents remain controversial [4]. A high
risk approach for all age groups is recommended by the
American Academy of Pediatrics (AAP) [5] and the
American Heart Association [6]. Universal screening of
children 9–11 years is proposed by the Expert Panel on
Integrated Guidelines for Cardiovascular Health and Risk
Reduction in Children and Adolescents (National Heart,
Lung, and Blood Institute; NHLBI) [7] and subsequently
included into the AAP Bright Futures schedule for well-
child supervision [8]. A systematic evidence review for the
US Preventive Services Task Force found insufficient
evidence to give any recommendations on screening and
treatment for hypercholesterolemia in children and ado-
lescents [9]. In Germany, the Working Group for pediatric
metabolic disorders (APS) of the German Society for
Pediatric and Adolescent Medicine (DGKJ) suggests a uni-
versal screening as part of the preventive check-up for
children at the age of 5 years (U9 screening) [10]. Notably,
children with familial hypercholesterinemia would benefit
from early diagnosis [11]. However, no universal lipid
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screening has been implemented in Germany as of Octo-
ber 2019 [10, 12].
There are a number of major unresolved issues about
universal lipid screening in children [9, 13]. Current
NHLBI integrated guidelines for cardiovascular health and
risk reduction in children and adolescents do not suffi-
ciently take into account physiological fluctuations in
serum lipid concentrations during growth and maturation.
Pubertal changes in serum lipids are considered by defi-
ning a specific age range for screening (9–11 years), which
is assumed to precede puberty in the majority of children.
During puberty hormonal changes associated with puber-
tal growth spurt and progressive maturation lead to
marked increases of cholesterol requirement and conse-
quently to decreases of lipid values [13]. Chronological
age as well as sexual maturation are likely to be independ-
ent determinants of serum lipid levels in children and ado-
lescents. Several cross-sectional [14–16] and longitudinal
[17–19] population-based studies of children and adoles-
cents have demonstrated that serum lipids increase with
age until puberty and decline thereafter. Nevertheless, the
interrelationship between serum lipid concentrations and
physical growth remains poorly understood. Few studies
have so far analyzed the distribution of serum lipids and
lipoprotein levels according to chronological age as well as
measures of pubertal status [18–21]. Moreover, the con-
founding effect of obesity, physical activity and dietary
habits has not been well studied despite the association
with lipid levels and considerable changes with age among
children and adolescents [22, 23]. Previous studies in the
US have shown that serum cholesterol levels vary accord-
ing to ethnicity [24, 25].
Using data from a large nationally representative
health survey of children and adolescents in Germany,
we analyzed and visualized the independent contribu-
tions of chronological age and pubertal status on sex-
specific distributions of serum lipids and lipoprotein
levels among children and adolescents 1–17 years of age.
We specifically asked whether findings were affected by
age- and puberty-related changes in obesity, physical ac-
tivity and dietary habits and also examined the interrela-
tionship between immigration background, pubertal
status and serum lipid concentrations.
Methods
Study design and study population
The German Health Interview and Examination Survey
for Children and Adolescents (KiGGS) was conducted
from May 2003 to May 2006 as a population-wide, na-
tionally representative cross-sectional survey based on
17,640 participants aged 0 through 17 years (8985 boys
and 8655 girls). The design, sampling strategy and study
protocol have been previously described in detail [26]. In
brief, based on a two-staged sampling procedure, first
167 study locations were selected proportional to the
distribution of communities in Germany according to
federal state, type of community, and population size. At
the second stage within each sample point, children were
sampled randomly from local population registries with
stratification by sex and age. The overall response rate
was 66.6%. We obtained written consent from parents of
all participating children irrespective of the child’s age
and additionally from participants 14 years of age and
older. The study was approved by the Ethics Committee
at the Charité Universitätsmedizin Berlin, Germany.
For the present analysis, we excluded children under
the age of 1 year (n = 935) and those with missing infor-
mation on serum cholesterol measures (assessed among
children 1 year of age and older; n = 2457). We also
excluded participants with diabetes mellitus (n = 18) and
those currently using lipid lowering drugs (n = 11),
systemic corticosteroids (n = 18) or oral contraceptives
(n = 391). Furthermore participants with missing informa-
tion on pubertal status (assessed among children 10 years
of age and older; n = 134) were excluded (Fig. 1). The final
study population comprised 13,676 children and adoles-
cents 1–17 years of age, 7187 boys and 6489 girls.
Data collection
Anthropometric measurements were performed by
trained staff members based on standardized study pro-
cedures. Body height was measured to the nearest 0.1
cm using a portable Harpenden Stadiometer (Holtain
Ltd., Crymych, UK). Body weight was measured wearing
only underwear to the nearest 0.1 kg with a calibrated
scale (SECA, Birmingham, UK) [26]. Body mass index
(BMI) was calculated as weight in kilograms divided by
Fig. 1 Flow diagram of study participants selection
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Fig. 2 Distribution of serum lipid levels by sex and pubertal stage provided with selected smoothing parameters. HDL-C: high-density lipoprotein
cholesterol; Non-HDL-C: non-high-density lipoprotein cholesterol; solid line = prepubertal stage, short broken line = pubertal stage, long broken
line = postpubertal stage
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the square of height in meters. Sex and age-specific BMI
z-scores were calculated according to Schaffrath-Rosario
et al. [27]. Obesity was defined using the International
Obesity Task Force definition [28]. Information on phys-
ical activity was obtained based on self-report using
standardized self-administered questionnaires for par-
ents and older children and adolescents as previously
described [26]. Information on current smoking was
collected among children and adolescents 11 years of age
and older based on self-report [29]. Participants were
asked: “Do you currently smoke?” “daily“, „several times
a week”,” once a week”,” more seldom” or “no”. To as-
sess the physical activity level, boys and girls 11 years
and older were asked how often they were physically ac-
tive in their leisure time in a way they sweat or breathe
hard: “every day”, “3 to 5 times a week”, “once to twice a
week” or “never” [30]. Parents of children younger than
11 years rated the physical activity level of their child.
Among 1–2 years of age the frequency of participation in
swimming courses/children’s gymnastics was assessed as:
“never”, “<1 time a week”, “≥1-2 times a week”, “every day”,
and “several times a day”. Among 3–10 year-olds physical
activity within and outside sports clubs was determined
based on following categories: “never”, “1-2 times a month”,
“1-2 times a week”, “3-5 times a week”, and “every day”
[30]. For analysis physical activity level was classified into
age-specific categories: low (1–2 years: never; 3–17 years: <
1 time a week), middle (1–2 years: <1 time a week; 3–10
years: 1–2 times a week; 11–17 years: 3–5 times a week)
and high (1–2 years: ≥1 time a week; 3–10 years: ≥3 times a
week: 11–17 years: every day). To assess the usual intake of
selected food groups a self-administered Food Frequency
Questionnaire was filled in by children 11 years of age and
older and parents of children younger than 11 years of age.
The Healthy Food Diversity Index (HFD) was calculated
based on 41 food items as described elsewhere [31]. The
index considers three aspects: the number (n), distribution,
and health value of all consumed foods and is bounded be-
tween 0 and 1–1/n. Higher HFD values reflect a healthier
diet. Information on ethnicity was not collected in the
KiGGS survey. Instead immigration background was
defined based on self-reported information on the parents’
country of origin. Children were defined as having an im-
migration background if at least one of the parents was not
born in Germany and/or had no German citizenship [32].
In this large epidemiological study self-assessed pu-
bertal hair growth was used as proxy for pubertal
status. Participants older than 10 years were asked to
provide self-estimates of pubertal hair growth pattern
assisted by standardized showcards displaying the six
Tanner stages [33, 34]. Pubertal status was classified
as prepubescent (Tanner stage 1), early/mid-puberty
(Tanner stages 2–3), or mature/advanced puberty
(Tanner stages 4–6) [35]. Pubertal stage was not
assessed among children younger than 10 years. For
the analysis children younger than 10 years were as-
sumed to have prepubescent status.
Venous blood samples were taken at the study centers
and the time of blood collection and hours since the last
food intake were recorded. Blood specimens were pro-
cessed within 1 h according to a highly standardized
protocol [36, 37], serum aliquots were frozen and trans-
ported on frozen cool packs at − 50 °C to a central
laboratory for analysis.
Laboratory assays
Serum total (TC) and high density lipoprotein choles-
terol (HDL-C) concentrations were analyzed in a central
University Hospital Laboratory (German Cardiology
Center, Virchow University Hospital, Charité, Berlin)
using a fully enzymatic cholesterol oxidase PAP method
and homogenous enzymatic color test (Roche, Mann-
heim, Germany) [37]. Non-HDL cholesterol (Non-HDL-
C) was calculated as the difference between TC and
HDL-C. Dyslipidemia was defined according to the Ex-
pert Panel on Integrated Guidelines for Cardiovascular
Health and Risk Reduction in Children and Adolescents
using the following cut-off values: TC ≥ 200 mg/dL,
HDL-C ≥ 40mg/dL and Non-HDL-C ≥ 145 mg/dL [7].
Statistical analysis
Analyses were conducted using SAS release 9.4 (SAS In-
stitute, Cary, NC). Tests were two-sided, and p-values <
0.05 were considered statistically significant. Prevalence
estimates or means and 95%-confidence intervals (95%-
CI) were calculated by sex and three age categories (1–9,
10–13, 14–17 years) for all study characteristics. The
Cochran-Armitage test for trend was applied to test for
group differences in categorical variables. Mean, median
(P50), and 95th percentile (P95) and 95%-CI were calcu-
lated for TC and Non-HDL-C [7] by strata of sex, five age
categories (1–2, 3–6, 7–9, 10–13, 14–17 years), and
Tanner stage among children and adolescents ≥10 years of
age. For HDL-C the 10th percentile was calculated [7].
Differences in demographic characteristics from the
official German population according to age, gender,
community size and residence were considered using
survey specific weighting factors in order to adjust for
the clustered sample design as well as non-response, as
previously described in detail [26]. To take into account
the weighting as well as the correlation of the partici-
pants within a community, the confidence intervals are
determined with the survey procedures for complex
samples of SAS 9.4.
For visualization of the age dependent development of
the lipoproteins according to sexual maturation we per-
formed locally weighted regression models (LOESS) and
presented the predicted values graphically. As
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information on pre- and pubertal stage in children youn-
ger than 10 years of age was not obtained in KiGGS,
some of the LOESS regression curves showed strong
fluctuations due to individual data. Curves with higher
smoothing parameters, which were chosen by visual in-
spection are presented in the manuscript. The original
plots are provided in Additional file 1, along with a
description of LOESS methods in Additional file 2.
Linear regression models were conducted to analyze
the association between various lipid parameters (TC,
HDL-C, Non-HDL-C) as dependent variables, and cat-
egories of pubertal status (prepubescent, early/mid-pu-
berty, mature/advanced puberty) as the independent
variable (Model 1). Model 2 was adjusted for chrono-
logical age by including a centered age-variable (sub-
tracting the sample mean stratified for sex) and a
centered and squared age-variable. Further adjustments
were done for body mass index (z-score BMI; Model 3)
and for behavioral determinants as smoking, nutrition
and physical activity (Model 4). To estimate the propor-
tion of variability estimated by the model the coefficient
of determination of regression models (R squared) was
used. Participants with missing values for any covariable
were excluded from the regression analyses. All analyses
were stratified for sex.
Results
As shown in Tables 1, 21.7% of boys and 47.0% of girls
10–13 years of age classified as mature/advanced puberty,
while the majority of boys (51.8%) and roughly one third
(30.2%) of girls in this age group had early/mid-puberty
status. In both sexes more than 90% of adolescents 14–17
years of age had mature/advanced puberty status. In both
sexes, mean body weight, body height, and BMI as well as
the prevalence of obese children increased with chrono-
logical age. The prevalence of highly physically active chil-
dren and adolescents significantly declined with age and
was consistently higher among boys than girls; this sex dif-
ference was most pronounced among adolescents 9–13
and 14–17 years of age. The HFD index declined with in-
creasing age, most pronounced among boys. The propor-
tion of children with immigration background did not
vary by age group (Table 1).
The prevalence of children meeting criteria for dyslip-
idemia according to guideline-based cutoff values varied
by sex and age categories. Among boys, the prevalence
of dyslipidemia based on TC cutoffs among boys 14–17
years of age was significantly lower compared to boys
10–13 years and 1–9 years of age (4.8% vs. 10.2% and
80%). Similar albeit less pronounced differences were
observed for Non-HDL-C, whereas the prevalence of
low-HDL-C showed substantial fluctuations across age
categories from 10.9% among boys 1–9 years of age to
6.3% among those 10–13 years of age to 15.1% among
boys 14–17 years of age (Table 1). Among girls, changes
in the prevalence of dyslipidemia across age categories
were less pronounced except for a substantially decreas-
ing prevalence in low HDL-C ranging from 12.8% in the
youngest to 5.6% in the oldest age group. While the
prevalence of dyslipidemia did not differ between sexes
among children 10–13 years of age, girls were signifi-
cantly more likely than boys to exceed cutoff criteria for
TC and Non-HDL-C in the youngest age group (Table
1). Among children 14–17 years of age, girls were also
significantly more likely than boys to exceed TC cutoff
criteria (9.6% vs. 4.8%) and significantly less likely than
boys to exceed HDL-C criteria (5.6% vs. 15.1%).
In both sexes, mean serum lipids generally increased
with age until age group 7–9 (until 3–6 years for Non-
HDL-C) and decreased thereafter (Tables 2 and 3).
Among children and adolescents 10 years of age and
older lipid concentrations, except HDL-C among girls,
consistently decreased with increasing Tanner stage.
Among boys, a distinct decline in mean serum lipid
levels was observed between Tanner stages 3 and 4,
whereas a gradual decline in mean lipid concentrations
with increasing Tanner stages was evident among girls.
Figure 2 presents the distribution of mean serum lipid
values according to sex, chronological age and pubertal
status. Beyond age 10 years, boys and girls at prepubes-
cent stages had considerably higher mean TC concentra-
tions compared to their peers at early/mid-puberty or
mature/advanced puberty status independent of chrono-
logical age. In both sexes, the nadir of mean TC was ob-
served among mature/advanced puberty at 15 years of
age (148mg/dL among boys vs. 159 mg/dL among girls).
Beyond this age, mean TC was observed to rise again.
Similar patterns were observed for mean Non-HDL-C.
The nadir for mean Non-HDL-C observed at age 15 years
amounted to 97mg/dL among boys vs. 102mg/dL among
girls. Mean TC was consistently higher among girls than
boys across all age groups and categories of pubertal sta-
tus. The age-related increase in Non-HDL-C beyond age
15 years was considerably steeper among boys than girls.
Differences between mature/advanced puberty vs. pre-
pubescent children were larger among boys than girls.
Boys 10 years and older with advanced pubertal stage had
significantly lower mean HDL-C compared to those of
prepubescent status. Among mature/advanced puberty
boys, mean HDL-C levels further decreased, whereas
mean HDL-C values did not substantially change with age
among mature/advanced puberty girls.
Among both sexes mature/advanced pubertal status
showed an inverse association with TC, HDL-C and Non-
HDL-C (Tables 4 and 5). Among girls, early/mid-puberty
status was associated with an increased HDL-C level. After
adjusting for chronological age pubertal status showed an in-
verse association with TC, HDL-C and Non-HDL-C among
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Table 1 Characteristics of the study population (n = 13,676)
% or Mean (95%-CI) N (missing) 1–9 years 10–13 years 14–17 years
Boys (n) 3529 1909 1749
Pubertal Stagea –
Prepubescent n.a. 26.5 (24.2–28.9) 0.1 (0.0–0.4)
Early/mid-puberty n.a. 51.8 (49.2–54.3) 5.7 (4.6–7.0)
Mature/advanced puberty n.a. 21.7 (19.6–24.0) 94.3 (92.9–95.4)
Dyslipidemiab –
TC ≥ 200 [mg/dL] 8.0 (7.0–9.1) 10.2 (8.6–12.0) 4.8 (3.8–5.9)
HDL-C < 40 [mg/dL] 10.9 (9.6–12.3) 6.3 (5.2–7.7) 15.1 (13.2–17.3)
Non-HDL-C ≥ 145 [mg/dL] 7.2 (6.2–8.3) 8.8 (7.4–10.5) 6.1 (5.1–7.4)
Anthropometry
Height (cm) 16 114.5 (113.9–115.1) 153.3 (152.7–153.8) 175.4 (174.9–175.8)
Weight (kg) 23 22.2 (21.9–22.4) 45.8 (45.1–46.5) 67.4 (66.6–68.1)
Body Mass Index (kg/m2) 34 16.3 (16.3–16.4) 19.2 (19.0–19.4) 21.8 (21.6–22.0)
Obesityc 24 (582) 3.4 (2.9–4.1) 4.7 (3.7–6.0) 6.5 (5.4–7.8)
Physical Activity/week 334
Low 26.8 (24.9–28.8) 25.2 (22.8–27.8) 38.1 (35.6–40.6)
Middle 32.6 (30.6–34.6) 36.2 (33.4–39.0) 36.9 (34.7–39.2)
High 40.6 (38.6–42.7) 38.6 (35.8–41.6) 25.0 (23.0–27.2)
Healthy Food Diversity Index 327 0.55 (0.54–0.56) 0.52 (0.51–0.52) 0.48 (0.47–0.49)
Smoking 40 n.a. 3.9 (2.8–5.3) 30.8 (28.4–33.3)
Immigration background 23 16.5 (14.3–19.0) 18.8 (16.1–21.9) 17.0 (14.5–19.7)
Girls (n) 3384 1805 1300
Pubertal Stagea –
Prepubescent n.a. 22.7 (20.5–25.1) –
Early/mid-puberty n.a. 30.2 (27.9–32.7) 3.5 (2.6–4.7)
Mature/advanced puberty n.a. 47.0 (44.6–49.4) 96.5 (95.3–97.4)
Dyslipidemiab –
TC ≥ 200 [mg/dL] 10.7 (9.5–12.1) 11.0 (9.6–12.5) 9.6 (7.8–11.7)
HDL-C < 40 [mg/dL] 12.8 (11.5–14.3) 7.5 (6.2–9.1) 5.6 (4.2–7.4)
Non-HDL-C ≥ 145 [mg/dL] 10.4 (9.1–11.8) 8.7 (7.3–10.2) 6.8 (5.2–8.8)
Anthropometry
Height (cm) 6 113.5 (113.0–114.1) 153.7 (153.3–154.2) 164.9 (164.5–165.3)
Weight (kg) 25 21.6 (21.4–21.8) 46.8 (46.1–47.5) 59.7 (58.9–60.5)
Body Mass Index (kg/m2) 30 16.2 (16.1–16.2) 19.6 (19.3–19.8) 21.9 (21.7–22.2)
Obesityc 26 (577) 3.5 (2.7–4.4) 4.7 (3.8–6.0) 5.5 (4.2–7.1)
Physical Activity/week 332
Low 26.6 (24.6–28.8) 40.5 (38.1–43.0) 61.2 (58.0–64.3)
Middle 36.9 (34.8–38.9) 31.9 (29.6–34.3) 25.4 (22.5–28.5)
High 36.5 (34.3–38.8) 27.6 (25.2–30.1) 13.4 (11.3–15.7)
Healthy Food Diversity Index 308 0.56 (0.55–0.56) 0.55 (0.54–0.56) 0.54 (0.53–0.55)
Smoking 20 n.a. 3.2 (2.3–4.4) 24.6 (22.0–27.3)
Immigration background 36 16.3 (14.2–18.7) 18.1 (15.5–21.1) 19.1 (16.0–22.5)
n.a. not assessed
aThe stage of puberty defined according to Tanner stage was only collected for boys and girls aged 10 years and older: prepubescent = stage 1, early/mid-
puberty = stage 2–3, and mature/advanced puberty = stage 4–6
baccording the Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents [7]
cObesity defined according to International Obesity Task Force [28]; not assessed at the age of 1–2 years (boys: N = 558, girls: N = 551)
Schienkiewitz et al. BMC Public Health         (2019) 19:1627 Page 6 of 14
both sexes. Results persisted after additional adjustment for
BMI z-score (Model 3). Further adjustment for behavioral
determinants did not materially change the results (Model
4). The difference in mean adjusted serum lipid concentra-
tions with advanced pubertal stage remained substantial: the
adjusted mean TC was 19.4mg/dL lower in mature/ad-
vanced puberty compared to prepubescent boys and 10.9
mg/dL lower in mature/advanced puberty compared to
prepubescent girls. Values for explained variance for the as-
sociation between pubertal status and different cholesterol
parameters adjusted for anthropometric variables were very
small except for HDL-C and consistently somewhat higher
among boys compared to girls (Tables 4 and 5). BMI z-score
was significantly associated with serum cholesterol parame-
ters (Model 3 and 4). The behavioral determinants showed
no independent associations with TC, HDL-C or non-HDL-
Table 2 Serum lipid levels in boys by age group and Tanner stage (≥ 10 years)
N TC [mg/dL] HDL-C [mg/dL] Non-HDL-C [mg/dL]
Age group 7187
1–2 Mean 558 153.0 (150.0–156.0) 47.9 (46.8–49.1) 105.1(102.0–108.1)
P50 151.1 (148.4–153.9) 48.0 (46.9–49.8) 102.7 (99.6–105.9)
P95/P10a 196.3 (189.8–202.7) 32.8 (30.5–35.0) 151.1 (141.9–160.3)
3–6 Mean 1544 163.3 (161.4–165.2) 55.6 (54.8–56.4) 107.7 (105.8–109.6)
P50 161.2 (159.2–163.2) 54.5 (53.5–55.5) 105.2 (103.3–107.2)
P95/P10 a 212.6 (206.5–218.7) 40.4 (38.9–41.8) 153.9 (149.1–158.6)
7–9 Mean 1427 165.2 (163.6–166.7) 60.0 (59.1–60.9) 105.1 (103.5–106.7)
P50 162.9 (160.7–165.1) 59.5 (58.8–60.5) 103.0 (101.0–105.0)
P95/P10 a 208.3 (205.8–210.9) 43.7 (42.4–45.1) 146.0 (143.1–148.9)
10–13 Mean 1909 164.5 (162.8–166.2) 59.0 (58.2–59.7) 105.6 (103.9–107.2)
P50 161.8 (160.1–163.5) 57.9 (56.9–58.9) 102.2 (100.3–104.1)
P95/P10 a 214.2 (209.7–218.8) 42.5 (41.5–43.5) 155.1 (151.8–158.4)
14–17 Mean 1749 152.3 (150.8–153.9) 51.4 (50.8–52.1) 100.9 (99.3–102.5)
P50 149.6 (147.8–151.3) 50.1 (49.2–51.0) 97.2 (95.6–98.9)
P95/P10 a 198.2 (195.0–201.5) 37.9 (37.2–38.6) 149.1 (145.0–153.1)
Tanner stage (≥10 years)b 3658
1 Mean 509 169.2 (166.1–172.3) 60.6 (59.4–61.9) 108.5 (105.6–111.5)
P50 166.9 (163.3–170.4) 60.5 (58.8–62.2) 105.3 (101.2–109.4)
P95/P10 a 213.1 (104.1–222.1) 43.3 (40.9–45.6) 154.2 (149.4–158.9)
2 Mean 727 167.5 (165.3–169.7) 59.7 (58.6–60.8) 107.8 (105.5–110.1)
P50 164.9 (162.1–167.7 58.9 (57.3–60.4) 104.4 (101.1–107.7)
P95/P10 a 215.9 (210.2 (221.7) 43.3 (42.0–44.6) 158.9 (153.6–164.1)
3 Mean 374 164.0 (160.5–167.5) 58.7 (57.1–60.4) 105.2 (101.7–108.8)
P50 161.0 (156.9–165.0) 57.0 (55.3–58.7) 101.7 (97.0–106.4)
P95/P10 a 217.1 (206.7–227.6) 42.7 (40.7–44.8) 156.4 (143.0–169.6)
4 Mean 458 154.1 (151.5–156.7) 54.0 (52.5–55.5) 100.2 (97.5–102.8)
P50 153.1 (150.0–156.2) 52.3 (50.5–54.1) 96.6 (93.8–99.5)
P95/P10 a 198.9 (192.7–205.1) 38.7 (36.8–40.6) 145.3 (139.9–150.7)
5 Mean 1069 150.0 (148.0–151.9) 51.9 (51.1–52.6) 98.1 (96.1–100.1)
P50 147.4 (144.8–150.0) 50.4 (49.4–51.4) 95.3 (93.5–97.2)
P95/P10 a 193.8 (189.0–198.5) 38.1 (37.2–38.9) 140.6 (124.0–147.3)
6 Mean 521 154.2 (151.5–157.0) 50.0 (49.0–51.0) 104.2 (101.5–106.9)
P50 151.3 (147.3–155.2) 49.1 (47.9–50.4) 100.9(98.3–103.6)
P95/P10 a 202.9 (196.0–209.8) 37.2 (35.7–38.7) 156.5 (148.9–164.0)
aP95 for TC and non-HDL-C and P10 for HDL-C according to the cut-offs for high plasma lipid concentrations for children and adolescents from the Expert Panel
on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents [7]
bThe stage of puberty defined according to Tanner stage was only collected for boys and girls aged 10 years and older
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C, except for smoking which was inversely associated with
HDL-C among girls (Model 4). Linear regression analyses
were repeated adding immigration background to the
models including pubertal status and chronological age
(Model 2). Immigration background did not independ-
ently contribute to this model and results regarding the
association of pubertal status with serum lipids persisted
(Additional file 3). There was also no evidence for first
order interaction, e. g. modification of the association
between pubertal status and serum lipids by immigration
background.
Discussion
In this large cross-sectional study, which was representa-
tive of German children and adolescents 1 through 17
years, we examined and visualized the distribution of
Table 3 Serum lipid levels in girls by age group and Tanner stage (≥ 10 years)
n TC [mg/dLl] HDL-C [mg/dL] Non-HDL-C [mg/dL]
Age group 6489
1–2 Mean 551 157.2 (154.4–160.0) 47.5 (46.3–48.8) 109.7 (107.0–112.4)
P50 155.9 (153.1–158.7) 46.8 (45.4–48.2) 107.5 (104.5–110.5)
P95/P10a 202.6 (194.2–211.1) 32.5 (30.1–34.9) 152.1 (148.3–155.8)
3–6 Mean 1484 166.8 (165.0–168.6) 54.4 (53.6–55.2) 112.4 (110.6–114.2)
P50 164.9 (163.0–166.7) 54.0 (53.2–54.8) 105.2 (103.3–107.2)
P95/P10 a 212.6 (209.7–215.6) 38.7 (37.4–40.0) 153.9 (149.1–158.6)
7–9 Mean 1349 170.8 (169.1–172.5) 59.2 (58.4–59.9) 111.6 (110.0–113.3)
P50 168.8 (167.3–170.4) 58.3 (57.4–59.2) 110.3 (108.5–112.1)
P95/P10 a 215.4 (210.8–219.9) 44.0 (42.8–45.2) 157.4 (151.3–163.5)
10–13 Mean 1805 165.5 (164.0–166.9) 57.4 (56.7–58.1) 108.1 (106.7–109.6)
P50 163.1 (161.5–164.6) 56.4 (55.5–57.3) 105.6 (104.1–107.2)
P95/P10 a 212.8 (207.9–217.6) 41.8 (40.8–42.8) 157.4 (152.7–162.1)
14–17 Mean 1300 162.1 (160.2–163.9) 57.9 (57.1–58.8) 104.1 (102.1–106.1)
P50 159.1 (157.3–161.0) 57.1 (56.2–58.1) 101.2 (98.7–103.7)
P95/P10 a 211.7 (206.9–216.5) 42.8 (41.7–44.0) 151.7 (145.9–157.4)
Tanner stage (≥10 years)b 3105
1 Mean 424 171.5 (168.7–174.4) 58.4 (57.0–59.8) 113.1 (110.3–116.0)
P50 168.2 (165.4–170.9) 57.7 (56.2–59.3) 109.0 (106.3–111.7)
P95/P10 a 219.7 (210.2–229.3) 41.4 (38.9–43.9) 164.2 (156.5–171.8)
2 Mean 336 167.0 (163.5–170.5) 57.7 (55.9–59.4) 109.3 (105.6–113.0)
P50 163.4 (159.5–166.9) 56.2 (54.1–58.3) 108.2 (104.1–112.2)
P95/P10 a 209.5 (201.0–218.0) 41.5 (37.8–45.2) 151.0 (141.7–160.3)
3 Mean 258 163.7 (159.9–167.6) 57.7 (56.0–59.4) 106.1 (101.9–110.3)
P50 162.9 (158.0–167.9) 57.1 (55.3–58.9) 106.2 (99.7–112.7)
P95/P10 a 208.8 (201.7–215.8) 42.3 (38.6–46.1) 146.1 (138.1–154.1)
4 Mean 685 163.9 (161.3–166.5) 57.5 (56.4–58.7) 106.4 (103.9–108.9)
P50 160.3 (157.4–163.3) 57.1 (55.8–58.3) 103.6 (100.9–106.3)
P95/P10 a 209.8 (203.5–216.2) 42.3 (40.7–43.8) 157.5 (149.3–165.6)
5 Mean 1110 161.5 (159.6–163.4) 57.6 (56.7–58.5) 103.9 (101.9–105.9)
P50 158.8 (156.7–16,094) 56.3 (55.3–57.3) 100.9 (98.7–103.0)
P95/P10 a 209.5 (203.0–216.0) 42.5 (41.3–43.7) 151.3 (143.6–159.0)
6 Mean 292 160.4 (156.0–164.8) 57.0 (55.4–58.6) 103.4 (99.2–107.7)
P50 155.8 (150.9–160.7) 56.3 (54.2–58.3) 98.9 (94.7–103.2)
P95/P10 a 217.1 (204.0–230.2) 42.9 (39.7–46.1) 156.2 (141.8–170.5)
aP95 for TC and non-HDL-C and P10 for HDL-C according to the cut-offs for high plasma lipid concentrations for children and adolescents from the Expert Panel
on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents [7]
bThe stage of puberty defined according to Tanner stage was only collected for boys and girls aged 10 years and older
Schienkiewitz et al. BMC Public Health         (2019) 19:1627 Page 8 of 14
serum lipoprotein concentrations according to sex,
chronological age, and different stages of sexual matur-
ation. The results of the present study add strong evi-
dence to previous observations that lipid concentrations
during puberty are highly variable and significantly differ
on average from lipid concentrations observed during
prepubescent and mature/advanced puberty stages. Fur-
thermore, the results were not explained by considerable
age-related changes in body mass index or behavioral
determinants of serum lipids, such as current smoking,
food diversity and physical activity. As previously shown
[18, 20], our results also emphasize pronounced sex
differences with regard to mean lipid concentrations
and fluctuations during natural growth and maturation.
Consequently, the prevalence of dyslipidemia as defined
by uniform NHLBI cut off values varied considerably by
age and sex, which underlines the need for population-
based reference data stratified by age, sex and pubertal
status.
During the pubertal growth spurt cholesterol is included
into the growing cells leading to decreases of lipid values.
The pubertal growth spurt among girls is characterized by
increased estrogen and progesterone levels and by
increased testosterone levels among boys [19, 38]. It starts
soon after the onset of puberty among girls and somewhat
later among boys [39]. The considerable sex-specific dif-
ferences in serum lipids in relation to sexual maturation
and pubertal growth spurt of girls and of boys lead to
more pronounced decreases of lipid values in boys com-
pared to girls, because male pubertal growth spurt is more
marked compared to that of girls [40].
While a representative sample of healthy French chil-
dren aged 7–20 years indicated only little variation of TC
and HDL-C according to age and gender [41], several
Table 4 Linear Regression of serum cholesterol parameters on pubertal stage among boys adjusted for age and behavioral
determinants (n = 6531)
TC [mg/dL] HDL-C [mg/dL] Non-HDL-C [mg/dL]
Model 1: unadjusted R2 0.04 0.04 0.01
Early/mid-puberty β (S.E.) 2.7 (1.2) * 3.0 (0.5) *** −0.3 (1.1)
Mature/advanced puberty β (S.E.) −10.8 (0.9) *** −4.5 (0.4) *** −6.3 (0.9) ***
Model 2: adj. For age R2 0.05 0.11 0.01
Early/mid-puberty β (S.E.) −4.3 (1.4) * −1.9 (0.7) * −2.4 (1.4)
Mature/advanced puberty β (S.E.) −18.7 (1.8) *** −6.8 (1.0) *** −11.8 (1.8) ***
Age β (S.E.) 0.2 (0.3) −0.9 (0.2)*** 1.2 (0.4)*
Age (squared) β (S.E.) −0.1 (0.0)* − 0.1 (0.0)*** 0.1 (0.0)*
Model 3: adj. For age, BMI R2 0.06 0.16 0.05
Early/mid-puberty β (S.E.) −4.5 (1.4) * −1.6 (0.7) * −2.9 (1.4) *
Mature/advanced puberty β (S.E.) −19.5 (1.8) *** −5.9 (1.0) *** −13.6 (1.7) ***
Age β (S.E.) 0.3 (0.3) −1.1 (0.2)*** 1.4 (0.3)***
Age (squared) β (S.E.) −0.1 (0.0)* − 0.2 (0.0)*** 0.1 (0.0)*
BMI β (S.E.) 2.5 (0.4)*** −2.9 (0.2)*** 5.4 (0.4)***
Model 4: adj. For age, BMI and behavioral determinants R2 0.06 0.16 0.05
Early/mid-puberty β (S.E.) −4.4 (1.4)* −1.6 (0.7) * −2.8 (1.4)
Mature/advanced puberty β (S.E.) −19.4 (1.8) *** −5.9 (1.0) *** −13.6 (1.8) ***
Age β (S.E.) 0.2 (0.4) −1.1 (0.2)*** 1.2 (0.4)*
Age (squared) β (S.E.) −0.1 (0.0)* −0.2 (0.0)*** 0.1 (0.0)*
BMI β (S.E.) 2.4 (0.4)*** −2.9 (0.2)*** 5.3 (0.4)***
Smoking (yes vs. no) β (S.E.) 1.5 (1.6) −0.8 (0.6) 2.3 (1.6)
Healthy food diversity index β (S.E.) 1.4 (2.5) −0.6 (1.2) 2.0 (2.6)
Low physical activity β (S.E.) 1.0 (1.0) −0.5 (0.4) 1.5 (0.9)
Middle physical activity β (S.E.) 0.3 (1.0) −0.4 (0.4) 0.7 (0.9)
Model 2: adjusted for age (centred and squared)
Model 3: adjusted for age (centred and squared) and BMI (kg/m2, z-score)
Model 4: adjusted for age (centred and squared), BMI (kg/m2, z-score), smoking, healthy food diversity index and physical activity
β Regression coefficient, S.E. Standard error, R2 proportion of variance explained by the model, Reference = prepubescent stage
*p < 0.05, **p < 0.001, ***p < 0.0001
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other previous studies based on age-specific analyses dem-
onstrated considerable variation according to chrono-
logical age [18, 20]. Furthermore, data of the present study
indicate substantial variation in serum lipid concentration
according to sexual maturation, independent of chrono-
logical age. Among boys, a steep decline in mean serum
lipid levels consistently occurred between Tanner stage 3
and 4, whereas among girls mean serum lipids except
HDL-C gradually declined between all Tanner stages.
These patterns are likely to reflect sex-specific differences
in pubertal growth spurt and are in accordance with
results from a number of previous studies considering
chronological age as well as pubertal maturation as poten-
tial determinants of serum lipid levels. Bertrais et al. [20]
reported that prepubescent children have higher mean
levels of TC and Triglycerides than those at mature/ad-
vanced puberty stage, but data for HDL-C and Non-HDL-
C was not collected in this previous study [42]. Eissa et al.
[18] also reported decreasing levels of TC and non-HDL-
C during puberty with differences according to sex and
race. Our finding of increasing TC values for boys and
girls of 16 years and above is supported by longitudinal
data from the Amsterdam Health and Growth Study [17]
and two nationwide cross-sectional US studies [14, 15].
Similarly, our finding of a considerably steeper pubertal
decline in HDL-C among boys than girls is in agreement
with previous population-based longitudinal studies of US
children and adolescents [18, 19].
Compared to prepubescent status higher HDL-C levels
were found in early-mid-puberty. This reflects the strong
increase in HDL-C levels with increasing chronological age
as well as the fact that all children younger than 10 years
were categorized as prepubescent. Adjusting for chrono-
logical age the effect for pubertal status reversed reflecting
the rise in HDL-C in early puberty and the decline in HDL-
C among girls and boys with mature or advanced pubertal
Table 5 Linear Regression of serum cholesterol parameters on pubertal stage among girls adjusted for age and behavioral
determinants (n = 5878)
TC [mg/dL] HDL-C [mg/dL] Non-HDL-C [mg/dL]
Model 1: unadjusted R2 0.01 < 0.01> 0.01
Early/mid-puberty β (S.E.) −1.3 (1.5) −2.3(0.7) ** −3.6 (1.5)
Mature/advanced puberty β (S.E.) −4.6 (0.9) *** 2.5 (0.4) *** −7.1 (0.9) ***
Model 2: adj. For age R2 0.02 0.08 0.02
Early/mid-puberty β (S.E.) −7.3 (1.7) *** −4.5 (0.8) *** −2.8 (1.8)
Mature/advanced puberty β (S.E.) −10.2 (2.0) *** −4.9 (0.8) *** −5.2 (1.9) *
Age β (S.E.) −0.3 (0.4) 0.2 (0.2) −2.8 (1.9)
Age (squared) β (S.E.) −0.1 (0.0)*** −0.1 (0.0)*** −5.2 (1.9)
Model 3: adj. For age, BMI R2 0.02 0.11 0.03
Early/mid-puberty β (S.E.) −7.4 (1.7) *** −4.3 (0.8) *** −3.2 (1.8)
Mature/advanced puberty β (S.E.) −10.7 (2.0) *** −3.9 (0.8) *** −6.8 (1.9) **
Age β (S.E.) −0.2 (0.4) 0.0 (0.2) −0.2 (0.4)
Age (squared) β (S.E.) −0.1 (0.0) −0.1 (0.0)*** 0.0 (0.0)
BMI β (S.E.) 1.2 (0.5)* −2.2 (0.2)*** 3.4 (0.5)***
Model 4: adj. For age, BMI and behavioral determinants R2 0.02 0.11 0.03
Early/mid-puberty β (S.E.) −7.6 (1.7) *** −4.4 (0.8) *** −3.2 (1.8)
Mature/advanced puberty β (S.E.) −10.9 (2.0) *** −3.9 (0.8) *** −7.0 (2.0) **
Age β (S.E.) −0.1 (0.4) 0.0 (0.2) −0.2 (0.4)
Age (squared) β (S.E.) −0.1 (0.0)** −0.1 (0.0) 0.0 (0.0)
BMI β (S.E.) 1.2 (0.5)* −2.2 (0.2)*** 3.4 (0.5)***
Smoking (yes vs. no) β (S.E.) −2.9 (2.0) −2.3 (0.9)* −0.6 (2.1)
Healthy food diversity index β (S.E.) 5.2 (2.8) 1.2 (1.5) 4.0 (2.6)
Low physical activity β (S.E.) 1.0 (1.0) −0.4 (0.5) 1.4 (1.0)
Middle physical activity β (S.E.) 1.1 (1.0) −0.5 (0.5) 1.6 (1.0)
Model 2: adjusted for age (centred and squared)
Model 3: adjusted for age (centred and squared) and BMI (kg/m2, z-score)
Model 4: adjusted for age (centred and squared), BMI (kg/m2, z-score), smoking, healthy food diversity index and physical activity
β Regression coefficient, S.E. Standard error, R2 proportion of variance explained by the model, Reference = prepubescent stage
*p < 0.05, **p < 0.001, ***p < 0.0001
Schienkiewitz et al. BMC Public Health         (2019) 19:1627 Page 10 of 14
status. Further adjustment for anthropometric indicators
slightly reduced the inverse association between HDL-C
levels and pubertal stage in our study. This is not surpris-
ing, because an age- and sex-specific measure of BMI (z-
scores) was used, and the prevalence of relative obesity
significantly increased with age. We have previously shown
in KiGGS that overweight and obesity are significantly and
positively associated to lipid measures and other cardiovas-
cular risk factors among adolescent boys and girls inde-
pendent of age and pubertal stage [22]. Increased duration
of physical activity [43] as well as a healthy diet including
whole grains, fish, fruits and vegetables [44] decrease TC
levels. In our study physical activity and healthy food diver-
sity showed no independent association with serum lipids
in linear regression analyses also adjusting for chronological
age and BMI. This may partly result from the complex
interrelationship with BMI which cannot be disentangled in
this cross-sectional study. We also cannot rule out that mis-
classification for behavioral determinants contributed to
underestimate the association with serum lipids in the
present study.
Our study has several limitations. First, KiGGS is a
cross-sectional survey and the results of the present
study preclude any conclusions on causality. Only longi-
tudinal data could give answers on tracking of individual
serum lipid levels during puberty. Second, the presented
KiGGS data based on non-fasting lipoprotein measure-
ments. Data from the US nationally cross-sectional
NHANES Survey 1999–2008 available for 12,774
children aged 3–17 years indicated that those who had
fasted and those who had not fasted before a lipid
screening test show only small differences, which are
probably not clinically important [45]. In a cohort with
type 1 diabetes patients aged 1–20 years fasting had no
relevant influence on TC and HDL-C [46]. Therefore,
we assume that fasting measurements would not change
our results. Third, we cannot exclude misclassification of
pubertal stage due to self-assessment. Moreover, pubic
hair status was used as proxy for Tanner stages, and
breast/genital stages as well as additional measures as
bone age or orchiometry were not obtained. Girls tend
to underestimate their puberty stage by Tanner drawings
and boys tend to overestimate their stage of develop-
ment [47]. Nevertheless, self-assessment of pubertal sta-
tus is an important time- and cost-saving tool in study
settings where direct examinations are not feasible [48].
Fourth, the ascertainment of pubertal stage might be in-
complete, as information on pubertal hair development
was collected only among children and adolescents 10
years and older, with nearly 50% of girls 10–13 years
showing an advanced pubertal stage. Secular trends in
pubertal acceleration have been well documented in US
and European girls [49] and boys [50], and the duration
of puberty has been prolonged [51]. Thus, we may have
underestimated the proportion of children already
undergoing puberty, especially among girls. Fifth, there
were limitations to the assessment of immigration back-
ground and behavioral determinants which were consid-
ered as covariables in the present analysis. Considerable
heterogeneity of the group of children with immigration
background may have masked an association with serum
lipids in the present study. The definition of immigration
background entirely relied on self-reported information
on the parents’ country of origin. In lack of any specific
information on ethnic background, further stratification
of analyses according to subgroups of children with im-
migration background was not possible. Physical activity,
dietary habits and smoking were assessed with self-
administered questionnaires involving the potential for
misclassification bias. Thus, the association of behavioral
determinants with serum lipids might have been
underestimated.
In the present study all R squared values were quite low.
The low estimates among girls may partly reflect mis-
classification for pubertal status and behavioral covariables
as described above in the limitations section. Nevertheless,
the aim of the regression analysis was not to examine the
explained variance in the model but rather to observe if
there was a change in the association between pubertal
stage and serum lipid levels under consideration of
anthropometric markers or behavioral factors.
Despite these limitations the results of the present study
are based on a large nationally representative sample of
1–17 year old children and adolescents in Germany and a
selection bias can be neglected [26]. Furthermore, the dis-
tribution of TC- and Non-HDL-C-levels in children and
adolescents across pubertal stages (prepubescent, early/
mid-puberty, mature/advanced puberty) generally corre-
sponded with previously published cross-sectional [21, 52]
and longitudinal studies [18, 19]. Thus, the results are
generalizable to western children and adolescents from
Europe and North America. Considering pubertal stage in
the assessment of lipid profiles in children and adolescents
has practical implications. A study from the US show that
TC levels in childhood explain 25–50% of the variability
of values in adulthood [53]. Moreover, it is well known
that tracking of unfavorable lipid and lipoprotein concen-
trations through life can induce processes of atheroscler-
otic cardiovascular changes [2, 3]. Unfavorable lipid values
often result in medical treatment by dietary interventions
and pharmacotherapy recommended by national guide-
lines [7]. The current US clinical guideline recommends
comprehensive lipid screening for age group 9–11 years as
a stable time for lipid assessment in children, based on the
rationale that this time point will precede the onset of pu-
berty for most children. Among 10–13 year old children
in KiGGS, 47% of girls and 26.5% boys were postpubertal
and 30.2% of girls and 51.8% of boys were pubertal. In
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addition, results from the Bogalusa Heart Study indicated
that children with abnormal lipid values may show a sub-
stantially decrease in lipid values in the absence of any
intervention [54]. The present results do not support
current recommendations for routine screening among 9–
11 year olds as the time of puberty is not suited for pre-
ventive serum screening. In Germany, universal screening
at the age of 5 years has been suggested by the Working
Group for pediatric metabolic disorders (APS) of the
German Society for Pediatric and Adolescent Medicine
(DGKJ) [10]. In KiGGS, 8% of five-year-old boys and
14% of five-year-old girls exceeded the NHLBI cut-off
for TC. Despite the fact that the age of 5 years precedes
the onset of puberty‚ the usefulness of uniform cut-off
values for the definition of dyslipidemia remains un-
clear. Longitudinal studies are necessary to investigate
the complex association between pubertal stage, puber-
tal growth spurt and serum lipids in childhood and
adolescence and tracking of lipid levels among specific
subgroups into adulthood. In addition, NHLIB guide-
line cut-off values are based on population-based re-
ference data derived about 20 years ago. Population-
based studies are needed to derive updated serum lipid
and lipoprotein distributions among children and
adolescents according to sex, chronological age and
pubertal status. These studies should be periodically
repeated in order to detect and explain changes over
time. A recent study of trends in serum lipid and lipo-
protein concentrations among US youths 6–19 years of
age found favorable changes over time, which were
consistent within subgroups of age, sex and ethnicity.
The authors of this previous study pointed out that it
would have been important to also stratify by pubertal
status, however this information was not available [55].
Conclusions
Results from this large nationwide study add to existing
evidence that circulating lipids and lipoproteins
undergo considerable and sex-specific changes during
physical growth and sexual maturation. Changes in TC,
HDL-C and non-HDL-C persisted after adjusting for
behavioral determinants. A general lipid screening
among children 9–11 years of age cannot be supported.
Longitudinal studies are needed to provide further
evidence on factors related to tracking of lipid levels
from childhood and adolescence into young adulthood.
Besides, periodically repeated population-based studies
of serum lipid distributions are needed to determine
physiological fluctuations in serum lipid concentrations
among children and adolescents according to sex,
chronological age and pubertal stage as well as changes
in trends of serum lipid and lipoprotein distribution
over time.
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